Ētahi atu korero ― Maori

Ko te Pigmented purpuric dermatoses (PPD) he roopu o nga ahuatanga kiri e tohuhia ana e nga waahi iti o te toto i raro i te kiri na te mumura o te kapi. I te nuinga o te wa ka tiimata te PPD he whero ki te papura ka huri hei koura‑parauri i muri mai ka kohia ano te hemosiderin.
Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.

Ko Schamberg disease te momo pigmented purpuric dermatoses (PPDs), he momo kiri mau tonu e tohuhia ana e nga wahi iti whero, papura ranei, me te piki haere o te tae o te kiri (painga he parauri, he whero, he kowhai ranei). E rima nga momo PPD: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot‑Blum purpura, eczematoid‑like purpura of Doucas and Kapetanakis. Schamberg disease (SD) e mohiotia ana ko progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressiva, Schamberg's purpura. Ka pa te nuinga ki nga tane me te nuinga o nga wa ka puta ki nga waewae o raro, engari ka puta ano ki nga huha, papa, katua, ringa ranei.
Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.

I tātarihia ngā kōrero mō ngā tūroro 113 me te PPD, tae atu ki te 38 i uru ki te kairōria kiri mō tēnei rangahau. Ko te momo haematō tino noa ko te mate a Schamberg (60.5%). Ko ētahi atu tikanga i te taha o te PPD ko te mate teitei toto (hypertension) (15.8%), te mate huka (diabetes) (10.5%), me ētahi atu. Ko ngā hītori o te rongoā i whakaatu ko ngā statins (13.2%), ngā aukau beta (beta blockers) (10.5%), me ētahi atu. Ko ngā take pea e hono ana ki te PPD ko te mate huringa hau (upper respiratory infection) (5.3%), te roanga o te tū ki te pehanga orthostatic teitei (orthostatic pressure) (2.6%), me te whakakorikori tinana (2.6%). I whakahaerehia te maimoatanga ki ngā tūroro 36 (94.7%) – oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.